Victoria Summers is a principal at ZS and the East Coast lead for the company’s patient health and equity accelerator. She is also used to being on the other side of the mic, hosting the company’s own podcast that focuses on the issue of patient centricity.

Victoria tackles a range of questions and discussion points around the subject of patient engagement and how the industry can and should reach out to the people who rely on their solutions.

How should information be communicated? How does communication and patient outreach tie into the ongoing and pressing challenge of promoting health equity? Will better engagement lead to the creation of more effective solutions? 

These are just some of the discussion points touched on in this episode. Tune in to discover Victoria’s take on these issues, and more. 

Victoria Summers is a principal at ZS and the East Coast lead for the company’s patient health and equity accelerator. She is also used to being on the other side of the mic, hosting the company’s own podcast that focuses on the issue of patient centricity.
Victoria tackles a range of questions and discussion points around the subject of patient engagement and how the industry can and should reach out to the people who rely on their solutions.
How should information be communicated? How does communication and patient outreach tie into the ongoing and pressing challenge of promoting health equity? Will better engagement lead to the creation of more effective solutions? 
These are just some of the discussion points touched on in this episode. Tune in to discover Victoria’s take on these issues, and more.

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning. 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;

The Top Line

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We’ll analyze the week’s biggest business news—from mergers and marketing to drug R&D and device development. Available every Friday morning.

 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We&rsquo;ll analyze the week&rsquo;s biggest business news&mdash;from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.
&nbsp;

Victoria Summers, principal at ZS Associates, discusses patient centricity.

Advertisement